Clinical pharmacy services in hematology can have a significant impact, and the Pharmacy Times® Hematology resource center provides clinical news and articles about the topic. Here, visitors will find information about upcoming hematology conferences and meetings, updated clinical trial listings, and other resources.
Further, these natural killer (NK) cells appear to be more effective the earlier they are in development, creating the possibility of an immunotherapy that would not use cells from a patient or a matched donor.
CAR NK cells are allogenic, which is defined as taking the cells from a non-related healthy donor rather than the patient themselves. Therefore, CAR NK cells have the potential to be manufactured in advance and stored for off-the-shelf immediate use.
Belantamab mafodotin has the potential for durable responses in patients with multiple myeloma whose disease has relapsed or is resistant to standard therapies.
The Pharmacy Times® Hematology specialty page serves as a hub for all clinical news and articles related to hematological conditions. The coverage includes updates from the floor of all the biggest societal conferences and annual meetings, like the American Society of Hematology Annual Meeting, as well as video interviews of the leading hematologists and key opinion leaders in the space.